203 related articles for article (PubMed ID: 22970185)
1. Development and validation of a prognostic gene-expression signature for lung adenocarcinoma.
Park YY; Park ES; Kim SB; Kim SC; Sohn BH; Chu IS; Jeong W; Mills GB; Byers LA; Lee JS
PLoS One; 2012; 7(9):e44225. PubMed ID: 22970185
[TBL] [Abstract][Full Text] [Related]
2. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
Zengin T; Önal-Süzek T
BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
[TBL] [Abstract][Full Text] [Related]
3. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
4. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
6. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
[TBL] [Abstract][Full Text] [Related]
7. Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.
Wan YW; Sabbagh E; Raese R; Qian Y; Luo D; Denvir J; Vallyathan V; Castranova V; Guo NL
PLoS One; 2010 Aug; 5(8):e12222. PubMed ID: 20808922
[TBL] [Abstract][Full Text] [Related]
8. A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer.
Wong KM; Ding K; Li S; Bradbury P; Tsao MS; Der SD; Shepherd FA; Chung C; Ng R; Seymour L; Leighl NB
Clin Lung Cancer; 2017 Jan; 18(1):e41-e47. PubMed ID: 27502323
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Chemotherapy Predictive Value of Gene-Expression Phenotypes in Primary Lung Adenocarcinoma.
Ringnér M; Jönsson G; Staaf J
Clin Cancer Res; 2016 Jan; 22(1):218-29. PubMed ID: 26265693
[TBL] [Abstract][Full Text] [Related]
10. Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.
Pio R; Agorreta J; Montuenga LM
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):986-92.e1-11. PubMed ID: 26162308
[TBL] [Abstract][Full Text] [Related]
11. Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma.
Chang YH; Chen CM; Chen HY; Yang PC
Sci Rep; 2015 Jun; 5():10979. PubMed ID: 26042604
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
Eguchi T; Kadota K; Chaft J; Evans B; Kidd J; Tan KS; Dycoco J; Kolquist K; Davis T; Hamilton SA; Yager K; Jones JT; Travis WD; Jones DR; Hartman AR; Adusumilli PS
Oncotarget; 2016 Jun; 7(23):35241-56. PubMed ID: 27153551
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
14. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
Zhang L; Zhang Z; Yu Z
J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
[TBL] [Abstract][Full Text] [Related]
16. Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer.
Oh SC; Park YY; Park ES; Lim JY; Kim SM; Kim SB; Kim J; Kim SC; Chu IS; Smith JJ; Beauchamp RD; Yeatman TJ; Kopetz S; Lee JS
Gut; 2012 Sep; 61(9):1291-8. PubMed ID: 21997556
[TBL] [Abstract][Full Text] [Related]
17. Identification of reproducible gene expression signatures in lung adenocarcinoma.
Lu TP; Chuang EY; Chen JJ
BMC Bioinformatics; 2013 Dec; 14():371. PubMed ID: 24369726
[TBL] [Abstract][Full Text] [Related]
18. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
Guo NL; Wan YW
Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
[TBL] [Abstract][Full Text] [Related]
19. Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients.
Ly D; Zhu CQ; Cabanero M; Tsao MS; Zhang L
Cancer Immunol Res; 2017 Sep; 5(9):821-829. PubMed ID: 28775209
[TBL] [Abstract][Full Text] [Related]
20. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
